Cent Health: Bringing AI-Powered Early Disease Detection into Preventive Healthcare

November 18, 2026 | Wednesday | Features

Moving healthcare beyond reactive treatment towards early disease detection, Cent Health is building an AI-powered preventive health intelligence platform that combines advanced medical imaging, biomarker analysis, genetics and specialist-led clinical assessment. Founded in 2025, the Bengaluru-based healthtech startup aims to identify potential health risks before symptoms appear and help individuals take informed action through continuous health monitoring.

Problem

Serious conditions such as cancer, cardiovascular disease and metabolic disorders can develop without noticeable symptoms. Conventional annual health check-ups often rely on limited blood tests and isolated assessments, leaving gaps in early detection. Cent aims to address this through an integrated approach to preventive health screening.

Product

Its flagship offering, Cent Check, combines full-body MRI, low-dose CT, DEXA scans, ECG, echocardiography and more than 100 blood and urine biomarkers. Its AI-powered platform integrates these findings into a comprehensive health report covering more than 300 health conditions, supported by specialist review, personalised recommendations and follow-up consultations through the Cent Health app.

Proof

Cent reported completing more than 1,500 scans during its initial months of operations, with 26% identifying clinically meaningful findings and 4% revealing critical conditions requiring immediate medical attention. By October 2026, the company reported that more than 10,000 people had used its check-up services.

People

Cent was founded by Shashank ND, founder of Practo; Anshul Khandelwal, former Chief Marketing Officer of Ola Electric; and Arpit Garg, former product leader at Lenskart. Arpit serves as Co-founder and Chief AI and Research Officer, while Anshul leads business as Co-founder and Chief Business Officer. The company also has a multidisciplinary team of radiologists and medical specialists.

Purse

In October 2026, Cent raised US$15 million in a Series A round, comprising equity and debt, led by Blume Ventures and existing investor South Park Commons. The round also saw participation from individual investors, including former Vodafone CEO Arun Sarin and former OpenAI executive Srinivas Narayanan. Earlier, the company had secured seed investment from OneFlow Holdings and South Park Commons.

Plan

Cent plans to expand its network of dedicated preventive healthcare centres across India while investing further in AI, medical imaging and clinical research. It aims to build a large-scale preventive health infrastructure supported by Indian health-data baselines and AI models that can improve early risk identification. Its long-term ambition is to enable 10 million scans and contribute to one million lives saved by 2035.

Why it matters

India's healthcare system has traditionally focused on treating diseases after symptoms emerge. Cent's integrated model brings together imaging, biomarkers, AI and specialist consultations to make preventive health assessments more comprehensive. Its approach reflects the growing role of health intelligence and early risk identification in the future of healthcare delivery.

FAST FACTS

Particulars

Details

Company

Cent Health

Inception

2025

Headquarters

Bengaluru, Karnataka, India

Industry

HealthTech, Preventive Healthcare, Medical Diagnostics

Founders

Shashank ND, Anshul Khandelwal, Arpit Garg

Key Leadership

Arpit Garg – Co-founder & Chief AI and Research Officer; Anshul Khandelwal – Co-founder & Chief Business Officer

Flagship Offering

Cent Check

Core Technology

AI, Advanced Medical Imaging, Biomarker Analysis

Screening Coverage

300+ health conditions

Key Diagnostics

Full-body MRI, CT, DEXA, ECG, ECHO, 100+ biomarkers

Latest Funding

US$15 million, Series A

Key Investors

Blume Ventures, South Park Commons

Website

cent.health

Disclaimer: This profile is based on publicly available company information and reported funding announcements.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

OR

Forgot your password?

OR

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy